The approach mechanistically inhibited the proliferation of BC cells MDA-MB-231 in vitro, downregulated the expression of Nrf2 and its downstream genes HO-1 and NQO1, and promoted ROS production and accumulation in these tumor cells. The gene discussed is NQO1; the disease is breast cancer.